Zhao Zehao, Deng Yanling, Deng Yu, Chen Zhuojun, Zhou Zhikun
Department of Pharmacy, Guangdong Medical University, Dongguan 523808, China.
Recent Pat Nanotechnol. 2023 Mar 24. doi: 10.2174/1872210517666230324103543.
Targeted nanoparticles' preparation can enhance local drug concentration and reduce the side effects of drugs in non-targeted organs. At present, many patents have been applied for in the field of bone-targeted nanoparticles' preparations. They play an important role in the treatment and diagnosis of diseases. In this experiment, nanoparticles with bone targeting function were prepared by poly(lactic-co-glycolic acid) (PLGA) copolymer and tetracycline. These nanoparticles contain active ingredients in the Huangqi Sanxian decoction, a kind of Traditional Chinese Medicine (TCM) compound formula. These nanoparticles are predicted to be useful in the treatment of osteoporosis.
Synthesis of tetracycline targeting groups was performed by acylation reaction, and PLGA nanoparticles were prepared by the Emulsification-solvent Evaporation Method. The appearance and particle size of the product were evaluated, and the effects of nanoparticles on the physiological activities of osteoblasts were observed. Finally, the bone-targeting ability of targeted nanoparticles in vivo and in vitro was investigated.
The average particle size of the nanoparticles was about 200 nm, and the average drug entrapment was 60%. In vitro evaluation of osteoblasts assay showed that the nanoparticles can be well taken by cells. Their good biocompatibility and sustained-release properties reduce the toxic side effects of drugs when they promote osteoblasts' physiological activities. The results of the in vitro and in vivo bone targeting ability assays showed that tetracycline modified nanoparticles could effectively accumulate in the bone, indicating the great bone-targeting ability of the nanoparticles. The use of PLGA to load active components in the TCM compound formulas and remodel targeting groups is expected to improve drug efficacy, reduce drug dosage, and effects on non- action sites. This may provide new ideas for the development of TCM compound dosage forms.
In summary, we prepared PLGA nanoparticles of multiple TCM ingredients with bone targeting ability, and they had good morphological appearance, and a promoting effect on various physiological activities of osteoblasts.
靶向纳米颗粒的制备可提高局部药物浓度,并减少药物在非靶向器官中的副作用。目前,骨靶向纳米颗粒制剂领域已申请了许多专利。它们在疾病的治疗和诊断中发挥着重要作用。在本实验中,通过聚乳酸-羟基乙酸共聚物(PLGA)和四环素制备了具有骨靶向功能的纳米颗粒。这些纳米颗粒含有中药复方黄芪三仙汤中的活性成分。预计这些纳米颗粒可用于治疗骨质疏松症。
通过酰化反应合成四环素靶向基团,并采用乳化溶剂蒸发法制备PLGA纳米颗粒。对产物的外观和粒径进行评估,并观察纳米颗粒对成骨细胞生理活性的影响。最后,研究了靶向纳米颗粒在体内和体外的骨靶向能力。
纳米颗粒的平均粒径约为200nm,平均载药量为60%。成骨细胞体外评价试验表明,纳米颗粒能被细胞良好摄取。它们良好的生物相容性和缓释性能在促进成骨细胞生理活性时降低了药物的毒副作用。体外和体内骨靶向能力测定结果表明,四环素修饰的纳米颗粒能有效在骨中蓄积,表明纳米颗粒具有很强的骨靶向能力。利用PLGA负载中药复方制剂中的活性成分并重塑靶向基团有望提高药物疗效、降低药物用量以及对非作用部位的影响。这可能为中药复方剂型的开发提供新思路。
综上所述,我们制备了具有骨靶向能力的多种中药成分的PLGA纳米颗粒,它们具有良好的形态外观,对成骨细胞的各项生理活性有促进作用。